company background image
A084990 logo

Helixmith KOSDAQ:A084990 Stock Report

Last Price

₩3.38k

Market Cap

₩155.6b

7D

-8.6%

1Y

-19.8%

Updated

11 Nov, 2024

Data

Company Financials

Helixmith Co., Ltd

KOSDAQ:A084990 Stock Report

Market Cap: ₩155.6b

A084990 Stock Overview

Develops biologic and natural nutraceutical products.

A084990 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Helixmith Co., Ltd Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Helixmith
Historical stock prices
Current Share Price₩3,380.00
52 Week High₩7,440.00
52 Week Low₩3,250.00
Beta1.08
11 Month Change-1.02%
3 Month Change-20.56%
1 Year Change-19.81%
33 Year Change-84.25%
5 Year Change-95.33%
Change since IPO-77.22%

Recent News & Updates

Helixmith (KOSDAQ:084990) Is In A Good Position To Deliver On Growth Plans

Oct 18
Helixmith (KOSDAQ:084990) Is In A Good Position To Deliver On Growth Plans

Recent updates

Helixmith (KOSDAQ:084990) Is In A Good Position To Deliver On Growth Plans

Oct 18
Helixmith (KOSDAQ:084990) Is In A Good Position To Deliver On Growth Plans

Would Shareholders Who Purchased Helixmith's (KOSDAQ:084990) Stock Three Years Be Happy With The Share price Today?

Feb 19
Would Shareholders Who Purchased Helixmith's (KOSDAQ:084990) Stock Three Years Be Happy With The Share price Today?

Shareholder Returns

A084990KR BiotechsKR Market
7D-8.6%5.6%0.8%
1Y-19.8%46.2%3.9%

Return vs Industry: A084990 underperformed the KR Biotechs industry which returned 46.2% over the past year.

Return vs Market: A084990 underperformed the KR Market which returned 3.9% over the past year.

Price Volatility

Is A084990's price volatile compared to industry and market?
A084990 volatility
A084990 Average Weekly Movement5.9%
Biotechs Industry Average Movement8.5%
Market Average Movement5.4%
10% most volatile stocks in KR Market11.4%
10% least volatile stocks in KR Market2.6%

Stable Share Price: A084990 has not had significant price volatility in the past 3 months compared to the KR market.

Volatility Over Time: A084990's weekly volatility has decreased from 11% to 6% over the past year.

About the Company

FoundedEmployeesCEOWebsite
1996107Ji-Wook Jeongwww.helixmith.com

Helixmith Co., Ltd develops biologic and natural nutraceutical products. The company offers LAYLA Tab for osteoarthritis; Allex and Allex i for hypersensitivity improvement; and Mnemosyne for memory improvement. Its lead gene therapy product is Engensis (VM202), which is in a phase III clinical trial for diabetic peripheral neuropathy and diabetic foot ulcer; a phase II clinical trial for amyotrophic lateral sclerosis (ALS) and claudication; and a phase I clinical trial for charcot-marie-tooth disease and coronary artery disease.

Helixmith Co., Ltd Fundamentals Summary

How do Helixmith's earnings and revenue compare to its market cap?
A084990 fundamental statistics
Market cap₩155.64b
Earnings (TTM)-₩54.42b
Revenue (TTM)₩3.17b

49.1x

P/S Ratio

-2.9x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A084990 income statement (TTM)
Revenue₩3.17b
Cost of Revenue₩1.96b
Gross Profit₩1.21b
Other Expenses₩55.63b
Earnings-₩54.42b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-1.18k
Gross Margin38.05%
Net Profit Margin-1,717.43%
Debt/Equity Ratio0.1%

How did A084990 perform over the long term?

See historical performance and comparison